SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-059911
Filing Date
2024-07-09
Accepted
2024-07-09 06:09:39
Documents
17
Period of Report
2024-07-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0209127-6k_immuron.htm 6-K 12786
2 IMMURON CEO STEVEN LYDEAMORE TO PRESENTATION AT SHAREWISE ea020912701ex99-1_immuron.htm EX-99.1 32179
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5117
4 GRAPHIC ex99-1_002.jpg GRAPHIC 32594
5 GRAPHIC ex99-1_003.jpg GRAPHIC 3344
6 GRAPHIC ex99-1_004.jpg GRAPHIC 222559
7 GRAPHIC ex99-1_005.jpg GRAPHIC 346404
8 GRAPHIC ex99-1_006.jpg GRAPHIC 351978
9 GRAPHIC ex99-1_007.jpg GRAPHIC 519442
10 GRAPHIC ex99-1_008.jpg GRAPHIC 308691
11 GRAPHIC ex99-1_009.jpg GRAPHIC 314608
12 GRAPHIC ex99-1_010.jpg GRAPHIC 311099
13 GRAPHIC ex99-1_011.jpg GRAPHIC 248511
14 GRAPHIC ex99-1_012.jpg GRAPHIC 383213
15 GRAPHIC ex99-1_013.jpg GRAPHIC 335198
16 GRAPHIC ex99-1_014.jpg GRAPHIC 390505
17 GRAPHIC ex99-1_015.jpg GRAPHIC 156227
  Complete submission text file 0001213900-24-059911.txt   5458066
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 241106271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)